Stocks managed a very strong recovery on Monday that was not an easy rally to explain, and Tuesday’s stock index indications were strong yet again as the election day is finally here. Similar to Monday, it seems the cyclical, materials and value stocks were shining brighter than the tech leaders that have done so well in 2020.

Many investors missed out on the recovery from March’s panic selling. Now those same investors are looking for new ideas about how to be positioned after the election and heading into 2021.

24/7 Wall St. reviews dozens of analyst research reports each day of the week with a goal of finding new ideas for investors and traders alike. Some of these daily analyst calls cover stocks to buy. Other calls cover stocks to sell or avoid. Remember that no single analyst call should ever be used as a basis to buy or sell a stock. Consensus analyst target data is from Refinitiv.

These are the top analyst upgrades, downgrades and initiations seen on Tuesday, November 3, 2020.

Clorox Co. (NYSE: CLX) was reiterated as Buy and its target price was raised to $268 from $263 at D.A. Davidson. The stock closed up over 4% at $216.03 on Monday and was indicated up another 1.1% at $218.50 on Tuesday.

Editas Medicine Inc. (NASDAQ: EDIT) was started with an Underperform rating at Robert W. Baird. The stock closed up 1.1% at $31.30 a share on Monday and was indicated down 3% at $30.35 on Tuesday. The company reports earnings in just two days.

EverQuote Inc. (NASDAQ: EVER) was maintained as Outperform and its target price was lowered to $55 from $65 at Oppenheimer. The stock closed up 3.2% at $34.58 a share on Monday, with a $61.71 consensus target price.

Genpact Ltd. (NYSE: G) was maintained as Buy but its price target was cut to $45 from $48 at Needham. The stock closed up 3.75% at $35.66 on Monday and has a $47.22 consensus target price.

Greenhill & Co. Inc. (NYSE: GHL) was downgraded to Underperform from Market Perform at Keefe Bruyette & Woods, which also cut its target price to $11.50 from $13.00. Shares closed up 1% at $13.06 on Monday and were indicated down almost 5% at $12.45 on Tuesday.

Hookipa Pharma Inc. (NASDAQ: HOOK) was started as Buy and a $21 price target (versus a $9.40 prior close) at Truist Securities.

Kimco Realty Corp. (NYSE: KIM) was raised to Buy from Hold and its target price was raised to $14 from $12 (versus a $10.45 prior close) at Truist Securities. It has a $13.36 consensus target price.

Monster Beverage Corp. (NASDAQ: MNST) was raised to Overweight from Equal Weight and its price target was raised to $90 from $87 at Morgan Stanley. The company is supposed to report earnings later in the week. Its stock closed up 1.7% at $77.92 per share on Monday and was indicated up another 2.4% at $79.80 on Tuesday.

Mosaic Co. (NYSE: MOS) was downgraded to Sector Perform from Sector Outperform at ScotiaBank.

NICE Ltd. (NASDAQ: NICE) was started with a Buy rating and a $280 price objective at BofA Securities. The stock closed up 0.6% at $229.60 on Monday with a $239.27 consensus target price.

PayPal Inc. (NASDAQ: PYPL) closed up almost 0.9% at $187.76 on Monday ahead of earnings and the post-earnings reaction was down 5.2% at $177.90 on Tuesday morning. Truist Securities maintained its Hold rating but cut its price target to $200 from $215. Wedbush Securities reiterated its Outperform rating and maintained its $220 price target. Rosenblatt maintained it as Buy but cut its target from $250 to $280. KeyBanc Capital Markets reiterated its Overweight rating but trimmed its target to $215 from $230.

Sally Beauty Holdings Inc. (NYSE: SBH) was maintained as Outperform but its target price was cut to $16 from $19 at Oppenheimer. Shares closed up 5.6% at $8.84 apiece on Monday, and they have a $14.06 consensus target price.

Skechers USA Inc. (NYSE: SKX) was downgraded to Neutral from Positive at Susquehanna. Its shares closed down 3.75% at $30.52 on Monday and were indicated up almost 1% on Tuesday. The stock previously had a $40.92 consensus target price.

Skyworks Solutions Inc. (NASDAQ: SWKS) was up 0.6% at $142.12 ahead of earnings and was indicated to open down around $141.75 on Tuesday. Needham reiterated it as Buy and raised its target to $200 from $170, and Wells Fargo reiterated it as Overweight and its raised target from $155 to $165. KeyBanc Capital Markets reiterated its Overweight rating and raised its target to $170 from $160. Raymond James reiterated its Outperform rating and raised its target from $155 to $170, and Mizuho reiterated its Buy rating and raised its target to $174 from $170.

SolarEdge Technologies Inc. (NASDAQ: SEDG) was downgraded to Perform from Outperform at Oppenheimer. The stock closed up almost 4% at $267.72 on Monday, but shares of the high-beta solar inverters player were indicated down 19% at $216.00 after the company missed sales estimates and had weaker than expected guidance.

Vericel Corp. (NASDAQ: VCEL) was named as the Bull of the Day at Zacks, which said restoring cartilage in sports medicine and rebuilding skin after severe burns give this small-cap big upside. Shares most recently closed at $19.08 and have a consensus price target of $26.48.

Waste Management Inc. (NYSE: WM) closed up 2.5% at $110.67 on Monday and was indicated up 1.15 at $111.85 on Tuesday after its earnings report. Oppenheimer reiterated its Outperform rating and raised its price target to $128 from $123. Raymond James reiterated it as Outperform and lifted its price target to $120 from $114.

Monday’s top analyst upgrades and downgrades included AbbVie, Alibaba, Archer Daniels Midland, Best Buy, Intel, Nikola, Peloton Interactive, SAP, Under Armour and Wynn Resorts.

Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.